This message was sent to ##Email## To advertise in this publication please click here March 4, 2021 .NEWS FROM SIO SIO Call for Volunteers Now Open SIO Interested in volunteering on an SIO Committee? Click the link below to review SIO Committee descriptions and apply! If you have any questions regarding eligibility or requirements, please email info@sio-central.org. APPLY NOW Continue Accessing the SIO2021 Platform SIO Thank you again for attending the SIO2021 Annual Scientific Meeting! As a reminder, your registration provides continued access to all virtual platform content through 6 April 2021. Remember to claim your CME credit, and continue exploring SIO member benefits. REVIEW RECORDINGS NOW  SPONSORED CONTENT Promoted by Varian Medical Systems WATCH | VarianVision Replay: Leading Through Crisis: Practical Advice for Leaders in Healthcare and Medicine WATCH | VarianVision Replay: COVID-19: Serving Patients While Coping with Stress, Burn-Out, and Emotional Toll Renew Your Membership to SIO and Unlock Full Member Benefits SIO An SIO membership provides you with numerous personal and professional benefits, resources for growth and support, access to the latest science, and more! Renew your membership today, and look forward to: Learning about the latest NCCN guideline updates as they are submitted by Society leadership. Applying for and serving on SIO member-only committees. Connecting with more than 600 professionals from around the world in order to expand your network and further your career. Receiving discounted registration to SIO's Annual Scientific Meeting and additional educational events. The opportunity to apply for and receive exclusive, member-only grant and scholarship opportunities. Access to timely, relevant education materials and IO-specific resources. Gaining the latest society and industry updates from SIO publications. Earning continuing education credit from online courses, webinars, podcasts, and on-demand Annual Meeting recordings. RENEW NOW  PRODUCT SHOWCASE OPuS One Clinical Study News Outcomes in the first 100 patients treated with the OsteoCool™ Radiofrequency Ablation System from the OPuS One trial were recently published in the November edition of the Journal of Vascular and Interventional Radiology (JVIR). Learn more about the largest prospective study in radiofrequency ablation for bone metastases. LEARN MORE .INDUSTRY NEWS Personalized Radioembolization Improves OS vs Standard Dosing in Advanced HCC OncLive Yttrium-90 glass microspheres administered in a personalized, dosimetric approach demonstrated a 16-month improvement in overall survival compared with a standard dosimetric approach in patients with unresectable hepatocellular carcinoma. READ MORE Nomogram for Predicting the Prognosis of Patients with Hepatocellular Carcinoma Presenting with Pulmonary Metastasis Dove Press Only a few studies have investigated the clinical features and outcomes of patients with pulmonary metastasis from hepatocellular carcinoma (HCC) at the initial diagnosis. This study aimed to evaluate the prevalence, risk factors and prognostic factors related to pulmonary metastasis and then construct a nomogram to predict the outcomes of patients with HCC presenting with pulmonary metastasis. READ MORE Molecular Imaging of Orthotopic Prostate Cancer With Nanobubble Ultrasound Contrast Agents Targeted To PSMA DocWire News Ultrasound imaging is routinely used to guide prostate biopsies, yet delineation of tumors within the prostate gland is extremely challenging, even with microbubble (MB) contrast. A more effective ultrasound protocol is needed that can effectively localize malignancies for targeted biopsy or aid in patient selection and treatment planning for organ-sparing focal therapy. READ MORE  FEATURED ARTICLE   Pancreatic Cancer Clinical Study Now Enrolling Patients Promoted by AngioDynamics DIRECT, a clinical study evaluating the effectiveness of IRE technology on stage III pancreatic cancer, is actively enrolling patients. DIRECT, initiated by AngioDynamics, is led by Co-Principal Investigators – Govindarajan Narayanan, MD, Chief of Interventional Oncology at Miami Cancer Institute and Robert C.G. Martin, MD, PhD, Surgical Oncology at the University of Louisville. Visit AngioDIRECT.com to learn more. LEARN MORE   Use of TDI During MRI/US Fusion-Guided Biopsy for Suspected Prostate Cancer DocWire News TDI of prostate lesions prelocated by MRI discriminates between cancerous and noncancerous lesions and further seems to enable characterization of PCa aggressiveness. This widely available U.S. technique may improve confidence in target lesion localization for tissue sampling. READ MORE In Vivo Imaging of Methionine Aminopeptidase II for Prostate Cancer Risk Stratification DocWire News Prostate cancer is one of the most common malignancies worldwide, yet limited tools exist for prognostic risk stratification of the disease. Identification of new biomarkers representing intrinsic features of malignant transformation and development of prognostic imaging technologies are critical for improving treatment decisions and patient survival. READ MORE   IO Insights Connect with SIO View the Web Version. Jason Zimmerman, Director of Publishing, Multiview, 469-420-2686 | Download media kit Brie Ragland, Content Editor, Multiview, 469-420-2604| Contribute news The Society of Interventional Oncology 2025 M Street, NW, Suite 800  |  Washington, DC 20036  202-367-1164  |  Contact Us  |  www.sio-central.org Click here to unsubscribe.  Learn how to add us to your safe sender list so our emails get to your inbox. ADVERTISE SUBSCRIBE PAST ISSUES   7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063